Skip to main content

To Mark World AIDS Day, Institute of Human Virology Releases Video on Dr. Robert Gallo

November 29, 2017

Dr. Robert C. Gallo

Video Provides Unique Perspective on the Life of a Legendary Scientist

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) released a video on Dr. Robert Gallo, a trailblazer in HIV research, in advance of World AIDS Day,  December 1.  While many know Dr. ‌‌Gallo for his pioneering work in AIDS research, the short video focuses on Dr. Gallo’s life and legacy in its entirety, including his pioneering discovery of human retroviruses.

Dr. Gallo is The Homer & Martha Gudelsky Distinguished Professor in Medicine and Co-founder & Director of the Institute of Human Virology at UMSOM, as well as co-founder & scientific director of the Global Virus Network (GVN).

This past year, Dr. Gallo turned eighty years old on March 23, 2017. While most researchers his age are enjoying retirement, Dr. Gallo is still working to better the human condition through advances in biomedical research.

He began his career by fighting the established orthodoxy to prove that retroviruses exist in humans, and was the first to identify a human retrovirus – human T cell leukemia virus, among the first viruses known to directly cause any human cancer and the only virus known to cause leukemia. This led the way to his most famous accomplishment: he co-discovered that HIV is the cause of AIDS, went on to develop the HIV blood test, and first reported many of the characteristics of HIV with his colleagues.

Dr. ‌‌Gallo continues to search for answers to mysteries that have vexed him for decades, including overseeing several ongoing studies such as an HIV vaccine trial in humans and discovering new causes of human disease.

In 1996, Dr. Gallo co-founded the IHV with colleagues Dr. Robert Redfield, The Robert C. Gallo, MD Endowed Professorship in Translational Medicine, Associate Director, Director of the Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine and Dr. William Blattner, who is retired since January 2016 and a Member of the IHV Board of Advisors.

Since its founding, the Baltimore-based Institute faculty and staff have grown from 50 to more than 300, and the Institute's patient base has grown from just 200 patients to currently nearly 20,000 in Baltimore and Washington, DC, and more than 1,000,000 in 10 African and 2 Caribbean nations since 2004.  IHV is also internationally renowned for its basic science research, which includes the search for a functional HIV “cure” and a promising preventive HIV vaccine funded largely by the Bill & Melinda Gates Foundation and, in part, by others especially the National Institute of Allergy and Infectious Diseases.

In 2011, Dr. Gallo co-founded the Global Virus Network (GVN) alongside his colleagues, Dr. William Hall of University College Dublin and the late Dr. Reinhard Kurth of the Robert Koch Institut.  The GVN is an international coalition of the world’s foremost medical virologists, comprising 40 Centers of Excellence in 24 countries, dedicated to identifying and researching, combatting and preventing, current and emerging pandemic viruses that pose a critical threat to public health and well-being.

Video: Dr. Robert Gallo: Six Decades in Science

The video, “‌Gallo,” can be found at


Dr. Gallo is pictured with his mother and father, and his sister, Judy,
who died of leukemia when she was 6 years old and he was 12 years old.

Dr. Gallo met his wife, Mary Jane, in high school in their hometown
of Waterbury, Connecticut.

 Dr. Gallo, pictured in the mid 1980’s, was at the National Cancer
Institute for 30 years prior to co-founding the Institute of Human
Virology at the University of Maryland School of Medicine in 1996.


 Dr. Gallo is pictured with colleagues in the 1980’s at the
National Cancer Institute.

In 1996, Dr. Robert Redfield (formerly of The Walter Reed Army
Medical Center) and Drs. William Blattner and Robert Gallo
(both formerly of the National Cancer Institute) co-founded the
IHV, which is the first center in the US - perhaps the world.

Dr. Gallo visits officials in Nigeria while supporting the work of
the Institute of Human Virology, Nigeria.


Institute of Human Virology
Nora Samaranayake
Chief Communications & Public Affairs Officer
(443) 823-0613 (phone)
(410) 706-1952 (fax)

Related stories

    Thursday, August 12, 2021

    UM School of Medicine's Institute of Human Virology Member Joins Scientific Advisory Committee of the Coalition for Epidemic Preparedness Innovations

    The Coalition for Epidemic Preparedness Innovations (CEPI) has announced that Alash'le Abimiku, PhD, Professor of Medicine at the University of Maryland School of Medicine (UMSOM) and scientist at UMSOM’s Institute of Human Virology (IHV) will join CEPI’s Scientific Advisory Committee for a three-year appointment. CEPI supports research and development programs in response to infectious outbreaks such as the current COVID-19 pandemic, as well as future pandemics. UMSOM’s Institute of Human Virology is a Global Virus Network (GVN) Center of Excellence.

    Wednesday, April 22, 2020

    Dr. Robert Gallo Featured on National Geographic’s “Jane Goodall: The Hope” on 50th Anniversary of Earth Day

    For the 50th anniversary of Earth Day on April 22, 2020, the National Geographic channel will broadcast back-to-back premieres of Photo Ark: Rarest Creatures and Jane Goodall: The Hope.

    Tuesday, December 04, 2018

    Institute of Human Virology Researchers Discover That a Bacterial Protein Promotes Cancer

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) announced today the discovery that DnaK, a protein of the bacterium mycoplasma, interferes with the mycoplasma-infected cell’s ability to respond to and repair DNA damage, a known origin of cancer.

    Wednesday, September 19, 2018

    Institute of Human Virology (IHV) Awarded $12M to Combat Opioid Epidemic Through Clinical Research Trials

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine will lead a $12 million dollar project to improve the morbidity and mortality of people with opioid use disorder (OUD). Utilizing a novel compound, IHV researches will implement a series of investigations, entitled SEARCH, to evaluate the underlying mechanisms of craving reduction as a strategy to prevent opioid misuse, dependence, and relapse. The grant is awarded through the National Institutes of Health’s (NIH) Helping to End Addiction Long-term (HEAL) Initiative, made possible through groundbreaking funding from the U.S. Congress.

    Tuesday, October 25, 2016

    "A Call to End HIV/AIDS in America" IHV Director Dr. Robert Gallo's Op-Ed in the Huffington Post

    As the new Administration is presented with great challenges facing the United States, one will be a longtime foe, the U.S. HIV/AIDS epidemic. Since President Barack Obama was elected in 2008, I have publicly called on our country’s leaders to utilize the largest global health initiative in history - the President’s Emergency Plan for AIDS Relief (PEPFAR) - as a model to address the U.S. epidemic.

    Monday, August 22, 2016

    Institute of Human Virology (IHV) Awarded $14.4M for HIV Vaccine Research

    The Institute of Human Virology (IHV) announced a $14.4M grant from NIAID to advance HIV vaccine research to solve a major challenge: produce long-lasting antibodies to protect against HIV infection.

    Thursday, March 10, 2016

    UM SOM Establishes Two Endowed Professorships Through Private Gifts and Matching State Funds

    University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that the School has been awarded matching funds from the Maryland Department of Business and Economic Development (DBED) as part of the Maryland E-Nnovation Initiative Fund program. The funds, when combined with private philanthropy, will enable UM SOM to establish two new endowed professorships – one in human virology and vaccine development, the other in surgical science and entrepreneurship.